Clene Q2 2024 Adj EPS $(1.06) Beats $(1.49) Estimate, Sales $91.00K Miss $100.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Clene (NASDAQ:CLNN) reported Q2 2024 adjusted EPS of $(1.06), beating the $(1.49) estimate, but sales of $91.00K missed the $100.00K estimate. Sales decreased by 66.17% compared to the same period last year.
August 07, 2024 | 12:27 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Clene's Q2 2024 EPS of $(1.06) beat estimates, but sales of $91.00K missed expectations and decreased by 66.17% YoY.
While Clene's EPS beat estimates significantly, the miss on sales and the substantial YoY decline in revenue may offset the positive EPS news, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100